default author photo

Ivette Orosa-Vázquez

affiliation not provided to SSRN

SCHOLARLY PAPERS

1

DOWNLOADS

30

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Safety and Immunogenicity of Anti-SARS-CoV-2 Conjugate Vaccine SOBERANA 02: Phase IIb Clinical Trial

Number of pages: 56 Posted: 01 Feb 2022
Instituto de Medicina Tropical Pedro Kouri, Havana Hygiene and Epidemiology Center, affiliation not provided to SSRN, affiliation not provided to SSRN, Finlay Vaccine Institute, affiliation not provided to SSRN, Finlay Vaccine Institute, Center of Molecular Immunology, Finlay Vaccine Institute, Center of Molecular Immunology, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Civilian Defense Scientific Research Centre, Immunoassay Center, affiliation not provided to SSRN, National Coordinating Center for Clinical Trials, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Finlay Vaccine Institute, Finlay Vaccine Institute, affiliation not provided to SSRN, Finlay Vaccine Institute, affiliation not provided to SSRN, affiliation not provided to SSRN, Pasteur Institute of Iran, Pasteur Institute of Iran, affiliation not provided to SSRN, Finlay Vaccine Institute, affiliation not provided to SSRN, Finlay Vaccine Institute, Finlay Vaccine Institute and Independent
Downloads 30 (1,318,317)

Abstract:

Loading...

conjugate vaccine, heterologous schedule, COVID-19, recombinant RBD, phase IIb clinical trial